ORIC Pharmaceuticals, Inc.
ORIC
$4.95
-$0.3099-5.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -127.85M | -119.87M | -110.78M | -101.76M | -100.70M |
| Total Depreciation and Amortization | 1.11M | 1.07M | 1.05M | 1.04M | 1.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.11M | 10.35M | 9.19M | 9.06M | 9.08M |
| Change in Net Operating Assets | 1.97M | -428.00K | 817.00K | -3.58M | 4.90M |
| Cash from Operations | -112.66M | -108.88M | -99.73M | -95.25M | -85.69M |
| Capital Expenditure | -1.19M | -1.03M | -685.00K | -757.00K | -849.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.33M | 1.47M | -79.77M | -117.29M | -42.55M |
| Cash from Investing | 22.14M | 445.00K | -80.46M | -118.05M | -43.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 126.72M | 126.59M | 126.50M | 211.08M | 85.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -168.00K | -169.00K | -169.00K | -395.00K | -227.00K |
| Cash from Financing | 126.55M | 126.43M | 126.33M | 210.69M | 85.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.02M | 17.99M | -53.85M | -2.61M | -43.43M |
